<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33355881</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>One nerve suffices: A clinically guided nerve ultrasound protocol for the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis (ALS).</ArticleTitle><Pagination><StartPage>1495</StartPage><EndPage>1507</EndPage><MedlinePgn>1495-1507</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-020-10323-6</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate diagnostic accuracy of a nerve ultrasound (US) protocol that is individualized to a patient's clinical deficits for the differentiation of amyotrophic lateral sclerosis with predominant lower motoneuron disease (ALS/LMND) and multifocal motor neuropathy (MMN).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single-center, prospective, examiner-blinded, diagnostic study in two cohorts. Cohort I (model development): Convenience sample of subjects with ALS/LMND or MMN according to revised El-Escorial or EFNS guidelines. Cohort II (model validation): Consecutively recruited treatment-na&#xef;ve subjects with suspected diagnosis of ALS/LMND or MMN. Cutoffs for 28 different US values were determined by Receiver Operating Curve (ROC) in cohort I. Area Under The Curve (AUC) of US was compared to nerve conduction studies (NCS). Diagnostic accuracy of US protocols, individualized according to clinical deficits, was compared to former rigid non-individualized protocols and to random examination site selection in cohort II.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">48 patients were recruited. In cohort I (28 patients), US had higher ROC AUCs than NCS, US 0.82 (0.12)&#xa0;(mean (standard deviation)), NCS (compound muscle action potential (CMAP) 0.60 (0.09), p&#x2009;&lt;&#x2009;.001; two-sided t-test). US models based on the nerve innervating the clinically most affected muscles had higher correct classification rates (CCRs, 93%) in cohort II than former rigid protocols (85% and 80%), or models with random measurement site selection (66% and 80%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinically guided US protocols for differentiation of ALS/LMND from MMN increase diagnostic accuracy when compared to clinically unguided protocols. They also require less measurements sites to achieve this accuracy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loewenbr&#xfc;ck</LastName><ForeName>Kai F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307, Dresden, Germany. kai.loewenbrueck@uniklinikum-dresden.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 01307, Dresden, Germany. kai.loewenbrueck@uniklinikum-dresden.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werner</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE), 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dittrich</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Elblandkliniken, 01662, Meissen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klingenberger</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reichmann</LastName><ForeName>Heinz</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Technische Universit&#xe4;t Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Storch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Rostock, 18147, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 18147, Rostock, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, 18147, Rostock, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Translational Neurodegeneration Section "Albrecht Kossel", University of Rostock, 18147, Rostock, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>03WKBH2F</GrantID><Agency>Bundesministerium f&#xfc;r Bildung, Wissenschaft, Forschung und Technologie</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009431" MajorTopicYN="N">Neural Conduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011115" MajorTopicYN="Y">Polyneuropathies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Als</Keyword><Keyword MajorTopicYN="N">Diagnosis</Keyword><Keyword MajorTopicYN="N">Mmn</Keyword><Keyword MajorTopicYN="N">Nerve conduction studies</Keyword><Keyword MajorTopicYN="N">Nerve ultrasound</Keyword></KeywordList><CoiStatement>The authors report no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>7</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33355881</ArticleId><ArticleId IdType="pmc">PMC7990818</ArticleId><ArticleId IdType="doi">10.1007/s00415-020-10323-6</ArticleId><ArticleId IdType="pii">10.1007/s00415-020-10323-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Schaik IN, et al. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database System Rev. 2005 doi: 10.1002/14651858.CD004429.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004429.pub2</ArticleId><ArticleId IdType="pubmed">15846714</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm A, et al. Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy. J Neurol. 2015;262(4):870&#x2013;880. doi: 10.1007/s00415-015-7648-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7648-0</ArticleId><ArticleId IdType="pubmed">25626722</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongbloed BA, et al. Comparative study of peripheral nerve Mri and ultrasound in multifocal motor neuropathy and amyotrophic lateral sclerosis. Muscle Nerve. 2016;54(6):1133&#x2013;1135. doi: 10.1002/mus.25391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25391</ArticleId><ArticleId IdType="pubmed">27571543</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewenbr&#xfc;ck KF, et al. Nerve ultrasound in the differentiation of multifocal motor neuropathy (MMN) and amyotrophic lateral sclerosis with predominant lower motor neuron disease (ALS/LMND) J Neurol. 2016;263(1):35&#x2013;44. doi: 10.1007/s00415-015-7927-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7927-9</ArticleId><ArticleId IdType="pubmed">26477025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cartwright MS, et al. Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(3):346&#x2013;351. doi: 10.1002/mus.22035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22035</ArticleId><ArticleId IdType="pmc">PMC3193580</ArticleId><ArticleId IdType="pubmed">21815172</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattay TW, et al. Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy. Eur J Neurol. 2017;24(9):1125&#x2013;1134. doi: 10.1111/ene.13344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13344</ArticleId><ArticleId IdType="pubmed">28681489</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S, et al. Peripheral nerve ultrasound in ALS phenotypes. Muscle Nerve. 2014 doi: 10.1002/mus.24431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreiber S, et al. Peripheral nerve atrophy together with higher cerebrospinal fluid progranulin indicate axonal damage in amyotrophic lateral sclerosis. Muscle Nerve. 2018;57(2):273&#x2013;278. doi: 10.1002/mus.25682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25682</ArticleId><ArticleId IdType="pubmed">28472860</ArticleId></ArticleIdList></Reference><Reference><Citation>Herraets IJT, et al. Nerve ultrasound improves detection of treatment-responsive chronic inflammatory neuropathies. Neurology. 2020;94(14):e1470&#x2013;e1479. doi: 10.1212/WNL.0000000000008978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008978</ArticleId><ArticleId IdType="pubmed">31959710</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>van Schaik IN, et al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol. 2006;13(8):802&#x2013;808. doi: 10.1111/j.1468-1331.2006.01466.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2006.01466.x</ArticleId><ArticleId IdType="pubmed">16879289</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve. 1991;14(11):1103&#x2013;1109. doi: 10.1002/mus.880141111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880141111</ArticleId><ArticleId IdType="pubmed">1745285</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkies IS, Lauria G. 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10&#x2013;12 December 2004, Naarden The Netherlands. Neuromuscul Disord. 2006;16(2):149&#x2013;156. doi: 10.1016/j.nmd.2005.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2005.12.003</ArticleId><ArticleId IdType="pubmed">16431105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanhoutte EK, Faber CG, Merkies IS. 196th ENMC international workshop: outcome measures in inflammatory peripheral neuropathies 8&#x2013;10 February 2013, Naarden The Netherlands. Neuromusc Disord. 2013;23(11):924&#x2013;933. doi: 10.1016/j.nmd.2013.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2013.06.006</ArticleId><ArticleId IdType="pubmed">23835324</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169(1&#x2013;2):13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidman CM, Al-Lozi M, Pestronk A. Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study. Muscle Nerve. 2009;40(6):960&#x2013;966. doi: 10.1002/mus.21431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21431</ArticleId><ArticleId IdType="pubmed">19697380</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimm A, et al. Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy. J Neurol. 2015 doi: 10.1007/s00415-015-7648-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7648-0</ArticleId><ArticleId IdType="pubmed">25626722</ArticleId></ArticleIdList></Reference><Reference><Citation>Delmont E, et al. Multifocal motor neuropathy with and without conduction block: a single entity? Neurology. 2006;67(4):592&#x2013;596. doi: 10.1212/01.wnl.0000234063.51897.20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000234063.51897.20</ArticleId><ArticleId IdType="pubmed">16924010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Paul P, Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68(19):1571&#x2013;1575. doi: 10.1212/01.wnl.0000260965.20021.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Nodera H, et al. Thinning of cervical nerve roots and peripheral nerves in ALS as measured by sonography. Clin Neurophysiol. 2014;125(9):1906&#x2013;1911. doi: 10.1016/j.clinph.2014.01.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.01.033</ArticleId><ArticleId IdType="pubmed">24657162</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedee HS, et al. Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathies. Neurology. 2017;88(2):143&#x2013;151. doi: 10.1212/WNL.0000000000003483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003483</ArticleId><ArticleId IdType="pubmed">27927940</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewenbr&#xfc;ck KF, et al. Practically applicable nerve ultrasound models for the diagnosis of axonal and demyelinating hereditary motor and sensory neuropathies (HMSN) J Neurol. 2018;265(1):165&#x2013;177. doi: 10.1007/s00415-017-8687-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8687-5</ArticleId><ArticleId IdType="pubmed">29185050</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>